You are here: |
---|
Accomodation:
Organising Committee:
Chairman:
Jaroslav Turánek (Veterinary Research Institute, Brno, Czech Republic) turanek@vri.cz
Andrew D. Miller (Veterinary Research Institute, Brno, Czech Republic) andrew.miller@kptherapeutics.com; miller@vri.cz
Milan Raška (Palacky University, Olomouc, Czech Republic) raskamil@uab.edu
Daniel Růžek (Veterinary Research Institute, Brno, Czech Republic) ruzek@vri.cz
Mirek Machala (Veterinary Research Institute, Brno, Czech Republic) machala@vri.cz
Programme:
Monday 29th May 2017
8:00 Breakfast
Morning session
9:00 – 9:30 Giulietta Maruggi (GSK, USA) – mRNA vaccination of HIV and Flu with LNPs and microemulsions
9:30 – 10:00 Heinrich Haas (BioNTech, Germany) – mRNA vaccination for cancer
10:00 – 10:30 Jan Novak (University of Alabama at Birmingham, Birmingham, AL, USA) – Antigen glycosylation heterogeneity and humoral immune responses – HIV-1 vaccine as an example
10:30 – 11:00 Coffee Break
Short presentations session – Project FIT
11:00 – 11:25 Jaroslav Turánek (Veterinary Research Instiute, Czech Republic) – Biocompatible nanomaterials and molecular adjuvants for construction of recombinant vaccines and application for noninvasive vaccination
11:25 – 11:40 Daniela Lubasová (Technical University Liberec, Czech Republic) – Nanofibre technology: production, charactrisation & bioapplications
11:40 – 11:55 Kateřina Nechvátalová (Veterinary Research Instiute, Czech Republic) – Pig models for preclinical testing at VRI animal facility
11:55 – 12:00 Discussion
12:00 Lunch
13:00 – 13:20 Milan Raška (Palacky University, Olomouc, Czech Republic) – Recombinant proteins and antibody epitope-mimicking polypetides for nanoparticular vaccines formulations
13:20 – 13:45 Nigel Temperton (University of Kent, UK) – Production & characterisation of virus pseudotypes
13:45 – 14:00 Ladislav Drož (Apigenex, Czech Republic) – The challenges of cGMP synthesis of drugs
14:00 – 14:15 Coffee break
14:15 – 14:35 Jana Macková (Institute of Hematology and Blood Transfusion, Prague, Czech Republic) – In vitro generation of HCMV specific T-lymphocytes using IVT mRNA
14:35 – 15:00 Petr Malý (Biocev, Prague, Czech Republic) – Protein binders derived from albumin-binding domain scaffold as immunosuppressive non-IgG alternatives controlling the IL-23/Th-17 pro-inflammatory axis
19:00 Social event
Tuesday 30th May 2017
8:00 Breakfast
Morning session
9:00 – 9:30 Abdullah Ely (Witts University, RSA) – Controlling HBV infection with RNA
9:30 - 10:00 Daniel Růžek (Veterinary Research Instiute, Czech Republic) – Treatment of zika and other viral infections with anti-viral drugs
10:00 - 10:30 James Parkinson (University of Westminster, UK) – LITA nanoparticles in cancer therapy
10:30 – 10:50 Coffee Break
10:50 – 11:20 Andrew D. Miller (Veterinary Research Instiute, Czech Republic) – Precision Therapeutic Approaches to disease treatment
11:20 – 11:50 Daniel Scherman (René Descartes Institute, Paris, France) – RNA and DNA therapeutic approaches to disease treatment
11:50 – 12:00 Discussion
12:00 Lunch
13:00 – 13:30 Christoph Johann (Wyatt, Germany) – Characterization of colloidal drug delivery systems using field-flow fractionation coupled to light scattering
13:30 – 14:00 Régis Tournabize (Pasteur Institute, France) – The challenge of bacterial infections
14:00 – 14:20 Miroslav Machala (Veterinary Research Institute, Czech Republic) – In vitro and in vivo nanotoxicology – current challenges
14:20 - 14:35 Coffee break
14:35 – 15:00 Nadia Tagnaouti (Precision Nanosystems, Canada) – Next-generation scalable manufacture of lipid/polymer-based and genetic vaccines
15:00 – 15:30 Alexander Dulebo (Bruker, Germany) New fast scanning on BioScope Resolve AFM to visualize cellular dynamics
19:30 Social event
Wednesday 31th May 2017
8:00 BreakfastBreakfas
Morning session
9:00 – 9:30 James Valdés (Veterinary Research Instiute, Czech Republic) – „Water, water…everywhere“ for an antiviral resistanc
9:30 – 10:00 Pavel Hozák (Institute of Genetics, Prague, Czech Republic) – New structures in the cell nucleus defined by advanced microscopy techniques
10:00 - 10:30 Ioanna Theodorou (Pasteur Insitute, Paris, France) – The power of an imaging platform
10:30 – 10:50 Coffee Break
10:50 – 11:20 Jens Waldeck (Bruker BioSpin MRI GmbH, Germany) – Optical/µCT imaging can get you in vivo insights in cancer detection, treatment and cure
11:20 – 11:40 Martin Kopecký (Pragolab, Leica, Prague, Czech Republic) Advanced techniques by Leica TCS SP8 for imaging by confocal microscopy
11:40 – 12:00 Melinda Bartok (Schaefer Technologie GmbH, Germany) Enhanced Darkfield Hyperspectral Microscopy of Label free Nano-Scale Samples in Situ
12:00 – 12:30 Coffee Break and Snack
Company presentations
12:30 – 13:00 Marco Portalupi (NanoSurf, Switzerland) – AFM in vitro microscopy and nanoinjection
13:00 – 13:30 Jan Vávra (JPK, Germany) – High-resolution and high-speed AFM simultaneous to optical microscopy
13:30 – 14:00 Harald Groen (Milabs) – A multimodality (SPECT-PET-CT-Optical) imaging platform for drug discovery and development in small and medium-sized animal models
14:00 – 14:30 Jens Waldeck (Bruker BioSpin MRI GmbH, Germany) – Advantages of PET/MRI in translational research: Just more than a logic imaging method combination
14:30 Closing ceremony